Identification of secreted proteins that reflect autophagy dynamics within tumor cells

Adam A. Kraya, Shengfu Piao, Xiaowei Xu, Gao Zhang, Meenhard Herlyn, Phyllis Gimotty, Beth Levine, Ravi K. Amaravadi, David W. Speicher

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Macroautophagy, a catabolic process of cellular self-digestion, is an important tumor cell survival mechanism and a potential target in antineoplastic therapies. Recent discoveries have implicated autophagy in the cellular secretory process, but potential roles of autophagy-mediated secretion in modifying the tumor microenvironment are poorly understood. Furthermore, efforts to inhibit autophagy in clinical trials have been hampered by suboptimal methods to quantitatively measure tumor autophagy levels. Here, we leveraged the autophagy-based involvement in cellular secretion to identify shed proteins associated with autophagy levels in melanoma. The secretome of low-autophagy WM793 melanoma cells was compared to its highly autophagic metastatic derivative, 1205Lu in physiological 3-dimensional cell culture using quantitative proteomics. These comparisons identified candidate autophagy biomarkers IL1B (interleukin 1, β), CXCL8 (chemokine (C-X-C motif) ligand 8), LIF (leukemia inhibitory factor), FAM3C (family with sequence similarity 3, member C), and DKK3 (dickkopf WNT signaling pathway inhibitor 3) with known roles in inflammation and tumorigenesis, and these proteins were subsequently shown to be elevated in supernatants of an independent panel of high-autophagy melanoma cell lines. Secretion levels of these proteins increased when low-autophagy melanoma cells were treated with the autophagy-inducing tat-BECN1 (Beclin 1) peptide and decreased when ATG7 (autophagy-related 7) was silenced in high-autophagy cells, thereby supporting a mechanistic link between these secreted proteins and autophagy. In addition, serum from metastatic melanoma patients with high tumor autophagy levels exhibited higher levels of these proteins than serum from patients with low-autophagy tumors. These results suggest that autophagy-related secretion affects the tumor microenvironment and measurement of autophagy-associated secreted proteins in plasma and possibly in tumors can serve as surrogates for intracellular autophagy dynamics in tumor cells.

Original languageEnglish (US)
Pages (from-to)60-74
Number of pages15
JournalAutophagy
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Autophagy
Neoplasms
Proteins
Melanoma
Tumor Microenvironment
Blood Proteins
Chemokine CCL8
Leukemia Inhibitory Factor
Secretory Pathway

Keywords

  • Autophagy
  • Biomarker
  • Cancer
  • Melanoma
  • Secretome

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Kraya, A. A., Piao, S., Xu, X., Zhang, G., Herlyn, M., Gimotty, P., ... Speicher, D. W. (2015). Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy, 11(1), 60-74. https://doi.org/10.4161/15548627.2014.984273

Identification of secreted proteins that reflect autophagy dynamics within tumor cells. / Kraya, Adam A.; Piao, Shengfu; Xu, Xiaowei; Zhang, Gao; Herlyn, Meenhard; Gimotty, Phyllis; Levine, Beth; Amaravadi, Ravi K.; Speicher, David W.

In: Autophagy, Vol. 11, No. 1, 01.01.2015, p. 60-74.

Research output: Contribution to journalArticle

Kraya, AA, Piao, S, Xu, X, Zhang, G, Herlyn, M, Gimotty, P, Levine, B, Amaravadi, RK & Speicher, DW 2015, 'Identification of secreted proteins that reflect autophagy dynamics within tumor cells', Autophagy, vol. 11, no. 1, pp. 60-74. https://doi.org/10.4161/15548627.2014.984273
Kraya, Adam A. ; Piao, Shengfu ; Xu, Xiaowei ; Zhang, Gao ; Herlyn, Meenhard ; Gimotty, Phyllis ; Levine, Beth ; Amaravadi, Ravi K. ; Speicher, David W. / Identification of secreted proteins that reflect autophagy dynamics within tumor cells. In: Autophagy. 2015 ; Vol. 11, No. 1. pp. 60-74.
@article{aa9cb2076f3340468c867851e133ff3f,
title = "Identification of secreted proteins that reflect autophagy dynamics within tumor cells",
abstract = "Macroautophagy, a catabolic process of cellular self-digestion, is an important tumor cell survival mechanism and a potential target in antineoplastic therapies. Recent discoveries have implicated autophagy in the cellular secretory process, but potential roles of autophagy-mediated secretion in modifying the tumor microenvironment are poorly understood. Furthermore, efforts to inhibit autophagy in clinical trials have been hampered by suboptimal methods to quantitatively measure tumor autophagy levels. Here, we leveraged the autophagy-based involvement in cellular secretion to identify shed proteins associated with autophagy levels in melanoma. The secretome of low-autophagy WM793 melanoma cells was compared to its highly autophagic metastatic derivative, 1205Lu in physiological 3-dimensional cell culture using quantitative proteomics. These comparisons identified candidate autophagy biomarkers IL1B (interleukin 1, β), CXCL8 (chemokine (C-X-C motif) ligand 8), LIF (leukemia inhibitory factor), FAM3C (family with sequence similarity 3, member C), and DKK3 (dickkopf WNT signaling pathway inhibitor 3) with known roles in inflammation and tumorigenesis, and these proteins were subsequently shown to be elevated in supernatants of an independent panel of high-autophagy melanoma cell lines. Secretion levels of these proteins increased when low-autophagy melanoma cells were treated with the autophagy-inducing tat-BECN1 (Beclin 1) peptide and decreased when ATG7 (autophagy-related 7) was silenced in high-autophagy cells, thereby supporting a mechanistic link between these secreted proteins and autophagy. In addition, serum from metastatic melanoma patients with high tumor autophagy levels exhibited higher levels of these proteins than serum from patients with low-autophagy tumors. These results suggest that autophagy-related secretion affects the tumor microenvironment and measurement of autophagy-associated secreted proteins in plasma and possibly in tumors can serve as surrogates for intracellular autophagy dynamics in tumor cells.",
keywords = "Autophagy, Biomarker, Cancer, Melanoma, Secretome",
author = "Kraya, {Adam A.} and Shengfu Piao and Xiaowei Xu and Gao Zhang and Meenhard Herlyn and Phyllis Gimotty and Beth Levine and Amaravadi, {Ravi K.} and Speicher, {David W.}",
year = "2015",
month = "1",
day = "1",
doi = "10.4161/15548627.2014.984273",
language = "English (US)",
volume = "11",
pages = "60--74",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Identification of secreted proteins that reflect autophagy dynamics within tumor cells

AU - Kraya, Adam A.

AU - Piao, Shengfu

AU - Xu, Xiaowei

AU - Zhang, Gao

AU - Herlyn, Meenhard

AU - Gimotty, Phyllis

AU - Levine, Beth

AU - Amaravadi, Ravi K.

AU - Speicher, David W.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Macroautophagy, a catabolic process of cellular self-digestion, is an important tumor cell survival mechanism and a potential target in antineoplastic therapies. Recent discoveries have implicated autophagy in the cellular secretory process, but potential roles of autophagy-mediated secretion in modifying the tumor microenvironment are poorly understood. Furthermore, efforts to inhibit autophagy in clinical trials have been hampered by suboptimal methods to quantitatively measure tumor autophagy levels. Here, we leveraged the autophagy-based involvement in cellular secretion to identify shed proteins associated with autophagy levels in melanoma. The secretome of low-autophagy WM793 melanoma cells was compared to its highly autophagic metastatic derivative, 1205Lu in physiological 3-dimensional cell culture using quantitative proteomics. These comparisons identified candidate autophagy biomarkers IL1B (interleukin 1, β), CXCL8 (chemokine (C-X-C motif) ligand 8), LIF (leukemia inhibitory factor), FAM3C (family with sequence similarity 3, member C), and DKK3 (dickkopf WNT signaling pathway inhibitor 3) with known roles in inflammation and tumorigenesis, and these proteins were subsequently shown to be elevated in supernatants of an independent panel of high-autophagy melanoma cell lines. Secretion levels of these proteins increased when low-autophagy melanoma cells were treated with the autophagy-inducing tat-BECN1 (Beclin 1) peptide and decreased when ATG7 (autophagy-related 7) was silenced in high-autophagy cells, thereby supporting a mechanistic link between these secreted proteins and autophagy. In addition, serum from metastatic melanoma patients with high tumor autophagy levels exhibited higher levels of these proteins than serum from patients with low-autophagy tumors. These results suggest that autophagy-related secretion affects the tumor microenvironment and measurement of autophagy-associated secreted proteins in plasma and possibly in tumors can serve as surrogates for intracellular autophagy dynamics in tumor cells.

AB - Macroautophagy, a catabolic process of cellular self-digestion, is an important tumor cell survival mechanism and a potential target in antineoplastic therapies. Recent discoveries have implicated autophagy in the cellular secretory process, but potential roles of autophagy-mediated secretion in modifying the tumor microenvironment are poorly understood. Furthermore, efforts to inhibit autophagy in clinical trials have been hampered by suboptimal methods to quantitatively measure tumor autophagy levels. Here, we leveraged the autophagy-based involvement in cellular secretion to identify shed proteins associated with autophagy levels in melanoma. The secretome of low-autophagy WM793 melanoma cells was compared to its highly autophagic metastatic derivative, 1205Lu in physiological 3-dimensional cell culture using quantitative proteomics. These comparisons identified candidate autophagy biomarkers IL1B (interleukin 1, β), CXCL8 (chemokine (C-X-C motif) ligand 8), LIF (leukemia inhibitory factor), FAM3C (family with sequence similarity 3, member C), and DKK3 (dickkopf WNT signaling pathway inhibitor 3) with known roles in inflammation and tumorigenesis, and these proteins were subsequently shown to be elevated in supernatants of an independent panel of high-autophagy melanoma cell lines. Secretion levels of these proteins increased when low-autophagy melanoma cells were treated with the autophagy-inducing tat-BECN1 (Beclin 1) peptide and decreased when ATG7 (autophagy-related 7) was silenced in high-autophagy cells, thereby supporting a mechanistic link between these secreted proteins and autophagy. In addition, serum from metastatic melanoma patients with high tumor autophagy levels exhibited higher levels of these proteins than serum from patients with low-autophagy tumors. These results suggest that autophagy-related secretion affects the tumor microenvironment and measurement of autophagy-associated secreted proteins in plasma and possibly in tumors can serve as surrogates for intracellular autophagy dynamics in tumor cells.

KW - Autophagy

KW - Biomarker

KW - Cancer

KW - Melanoma

KW - Secretome

UR - http://www.scopus.com/inward/record.url?scp=84923367765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923367765&partnerID=8YFLogxK

U2 - 10.4161/15548627.2014.984273

DO - 10.4161/15548627.2014.984273

M3 - Article

C2 - 25484078

AN - SCOPUS:84923367765

VL - 11

SP - 60

EP - 74

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 1

ER -